No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BEN240517C27500
- 0.04
- +0.01+33.33%
15min DelayTrading May 15 09:30 ET
0.06High0.04Low
0.06Open0.03Pre Close2 Volume607 Open Interest27.50Strike Price10.00Turnover85.05%IV12.22%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.04Time Value100Contract SizeAmericanOptions Type0.0561Delta0.0657Gamma613.50Leverage Ratio-0.0310Theta0.0001Rho34.42Eff Leverage0.0023Vega
Intraday
- 5D
- 1D
News
Express News | NYSE Order Imbalance 168593.0 Shares on Buy Side
Deutsche Bank Trims Franklin Resources Price Target to $23 From $24
Franklin Resources (BEN) has an average rating of Underperform and price targets ranging from $23 to $28, according to analysts polled by Capital IQ. Price: 24.18, Change: +0.04, Percent Change: +0.17
Analysts Offer Insights on Financial Companies: Franklin Resources (BEN), SLR Investment Corp. (SLRC) and Hippo Holdings (HIPO)
Express News | Franklin Resources Inc: Preliminary Month-End Assets Under Management Aum of $1.60 Trillion at April 30 Compared to $1.64 Trillion at March 31
Franklin Resources AUM Slips 2.5% in April on Negative Market Action
Franklin Resources, Inc. Announces Month-End Assets Under Management
Franklin Resources, Inc. (Franklin Templeton) (NYSE:BEN) today reported preliminary month-end assets under management (AUM) of $1.60 trillion at April 30, 2024, compared to $1.64 trillion at March 31, 2024. This
Comments
Morning mooers! It is Monday, April 29th, and the market is open and chugging away on most recent earnings. This week is the most jam packed earnings week so far, with 175 firms in the S&P 500 reporting.
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
14
$Amylyx Pharmaceuticals(AMLX.US$
I have no doubt in Franklin, especially when both are together in one stock![]()
. I think both $Franklin Resources(BEN.US$ and $Franklin Biotechnology Discovery Fund(LU0109394709.MF$ are here. I don't know the second one could not link to AMLX.US, is it his holding company?
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
I have no doubt in Franklin, especially when both are together in one stock
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
2
Insider selling, especially the large scale by Alok Sethi and lack of buying in past year, creates concern despite high level of insider ownership. The sale above the current share price does not reveal insider sentiment about company value.
Franklin Templeton eyes significant growth in Canada, expecting Andrew Ashton's expertise to fuel expansion. The potential acquisition of Putnam Investments may unlock new opportunities.
Market overreactions and irrational behavior of investors may lead to discrepancies between a company's fundamentals and its stock performance. The drop in Franklin Resources' stock may be due to past unreasonable growth expectations or a potential one-off gain or loss that is ignored.
Read more